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IT is well recognised that a malabsorptive syndrome may occur in association
with a reticulosis involving the small bowel (Sleisenger, Almy and Barr, 1953
Kent, 1964).
Creamer (1964) and Hindle and Creamer (1965) have reported abnormalities
in the intestinal mucosa in patients with malignant disease. Dymock (1965) has
shown impairment of xylose absorption in similar patients. The association of
disordered folic acid metabolism with malignant disease has become increasingly
clear in recent years (Kershaw and Girdwood, 1964; Dymock, 1964; Rose, 1966)
and it seems likely that these abnormalities are related. In view of these findings
a study of stool fat excretion was carried out in patients suffering from neoplastic
disease.
MATERIALS AND METHODS
Fourteen patients suffering from neoplastic disease were studied; the sites of
the primary growth are detailed in Table I. The diagnosis was based on clinical,
haematological and radiological grounds, and was confirmed by histological
examination in all patients. In only four patients (t in Table I) had cytotoxic
drugs been administered and in no instance had abdominal radiotherapy been
given.
Stool fat excretion was measured as stearic acid by the method of van de
Kamer, ten Bokkel and Huinink (1949). A minimal three-day stool collection
was made in each patient; the excretion was expressed as an average in grams
per twenty-four hours. A normal ward diet was taken throughout the test.
The haematological methods were as described by Dacie and Lewis (1963).
UJrinary urocanic acid and formiminoglutamic acid were measured in the eight
hours following a 15 g. 1-histidine load using the method of Chanarin and
Bennett (1962) ; the normal range for this laboratory is 0-25 mg.
Urinary d-xylose excretion was measured in the five hours following a 5 g.
oral load (by the method of Santini, Sheehy and Martinez-de-Jesus (1961).
Normal range 1-2 to 2-4 g. in five hours).
RESULTS
See Tables I and II.
In six patients the twenty-four hour fat excretion exceeded 5-0 g. and in five of
these the result was 6.0 g. or more (range 5-5-10f2 g.). The other eight patients
exereted from 1-1 to 4-8 g.per twenty-four hours. In no patient was there overt
steatorrhoea.
A jejunal biopsy was obtained from three ofthe six patients; in two ther was
partial villous atrophy and in the third there was blunting of the villi. In five of
* Present address: Gastrointestinal Unit, Western General Hospital, Edinburgh, 4.ENTEROPATHY IN MALIGNANT DISEASE
these six patients an abnormal excretion of urocanic acid and formiminoglutamic
acid occurred, and in all six the xylose test was abnormal.
In seven of the fourteen patients the haemoglobin level was 12-0 g. or less and
in three of these macrocytosis was present in the peripheral blood film. Two of
the three patients with macrocytosis had a stool fat excretion in excess of 6 g.
TABLE I. Clinical Data and Faecal Fat Excretion in Fourteen Patients
Patient
numbei Diagnosis
Reticulum cell
sarcomat
' Carcinoma of
bronchus
3 Hodgkin's
diseaset
4 Hodgkin's
diseaset
5 Carcinoma of
stomach
6 Chronic lymphatic
leukaemia
7 Carcinoma of
bronchus
8 Carcinoma of
bronchus
9 MIyelofibrosis
10 Carcinoma of
bronchus
11 Carcinoma of
bronchus
12 Carcinoma of
bronchus
13 Hodgkin's
diseaset
14 Retroperitoneal
sarcoma
Sex and
age
F.59
M.59
* M.56
F.32
F.70
M.74
M.69
* M.56
F.66
M.83
F.64
M.67
M.49
M.58
Stool fat
excretion
Haemoglobin Blood film g./24 hours
13- 0 . Normal . 6- 0
8- 6 . Hypochromic
9 5 . Macrocytosis
Anisocytosis
Poikilocytosis
13- 7 . Normal
15-9
14-6
12-3
11*0
. Normal
. Normal
. Normal
. Normal
8- 3 . Anisocytosis
Poikilocytosis
12- 2 . Normal
11-8
12-2
10-2
10-6
. Normal
. Normal
. Macrocytosis
Anisocytosis
Poikilocytosis
. Macrocytosis
Anisocytosis
Poikilocytosis
10-2
7*6
1*1
7-6
2-6
1*6
5* 5
1-0
3-1
4-8
32'
6-4
2-9
t Receive(d cytotoxic drug therapy.
TABLE II.-Investigations in Six Patients with a Stool
of 5 g. per Twenty-four Hours
Stool fat
Patient excretion
number Primary lesion g./24 hours
1 Reticulum 6- 0
cell sarcoma
2 Carcinoma of . 10-2
bronchus
3 . Hodgkin's 7-6
disease
5 Carcinoma of 7-6
stomach
8 Carcinoma of . 5.5
bronchus
13 * Hodgkin's 6-4
disease
Xylose
excretion
g. in 5 hours
0-6
02 2
0 3
0 4
0 4
0 9
Fat Excretion in Excess
Urocanic acid +
formiminoglutamic
acid mg./8 hours
77
Jejunal
biopsy
157 . Partial villous
atrophy
310 . Blunting of villi
33
209 . Partial villous
atrophy
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DISCUSSION
Kent (1964) in a review of the literature traced forty-four cases of reticuloses
associated with small bowel involvement and a malabsorption syndrome and has
added three further cases of his own. He concludes that reticuloses supervene
on the sprue syndrome and evidently rejects the alternative explanation-that
the sprue syndrome is a complication ofreticulosis. Creamer (1964) studied nine
patients with neoplasia and reported jejunal mucosal abnormalities in six; stool
fat excretion in excess of 6 g. per twenty-four hours occurred in five of seven
patients.
In this communication the occurrence of an abnormal stool fat excretion is
reported in patients who were not suffering from reticulosis and in whom the
malignant growth did not involve the small intestine. Two ofthe six patients had
bronchogenic carcinoma and one sufferedfrom carcinoma ofthe stomach. Patients
2, 5 and 13 have since died; at postmortem examination there was no evidence
of direct involvement of the small bowel or of the mesenteric lymph nodes by
the tumour.
Progressive loss of weight, anaemia and deterioration of general health (the
cachectic state) are classic signs of malignant neoplasm, irrespective of the site of
the lesion. It is suggested that a concurrent enteropathy may be an important
factor contributing to these constitutional upsets.
SUMMARY
Abnormal stool fat excretion was found in six of fourteen patients with neo-
plastic disease. There was additional evidence in these six patients warranting
the diagnosis of an enteropathy. The possible significance of this finding is
discussed.
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